Funding rounds/CRISPR Therapeutics

CRISPR Therapeutics

Series A

Basel, SwitzerlandFounded 2013Mar 2014

Amount raised

€23M

€22,500,000

Native amount

22,500,000 EUR

Stage

Series A

series a

Investors

Provenance & confidence

Unverified

Amount

Reported in EUR — no conversion. €23M

High confidence

Source

No source on record — unverified.

Unverified

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Date

Mar 2014

Round type

series a

Amount (EUR)

€23M

same company